This podcast is supported by the Icon School of Medicine at Mount Sinai, one of America's leading research medical schools.

Icon Mount Sinai is the academic arm of the eight hospital Mount Sinai health system in New York City.

It's consistently among the top recipients of NIH funding.

Researchers at Icon Mount Sinai have made breakthrough discoveries in many fields vital to

advancing the health of patients, including cancer, COVID and long COVID, cardiology, neuroscience, and

artificial intelligence. The Icon School of Medicine at Mount Sinai, we find a way. Morgan State

University, a Baltimore, Maryland,

Carnegie R2 doctoral research institution, offers more than 100 academic programs and awards

degrees at the baccalaureate, master's, and doctoral levels, is furthering their mission of

growing the future leading the world. Morgan continues to address the needs and challenges of the modern urban environment.

With a four-year quadrupling of research, more than a dozen new doctoral programs,

and eight new national centers of excellence, Morgan is positioned to achieve Carnegie R1

designation in the next five years.

To learn more about Morgan and their

ascension to R1, visit Morgan.edu slash research.

Welcome to the science podcast for February 7, 2020. I'm Sarah Crespi. On this week's show,

staff writer Jennifer Cousin-Frankle joins us to talk about a study that combines two hot

areas of research, CRISPR gene editing and immunotherapy for cancer. These two things come together

in the study and are tested in patients. And researcher

Damian Finch joins us from Australia. He's going to talk about dating Ice Age cave

paintings using nearby wasp nests. Now we have staff writer Jennifer Cousin-Frank. She wrote a story this week on CRISPR and cancer

immunotherapy. Two big ideas mushed together for the first time in human patients. Hi, Jennifer.

...